Fulcrum therapeutics to participate at upcoming 2022 bofa securities biotech smid cap conference

Cambridge, mass., dec. 01, 2022 (globe newswire) -- fulcrum therapeutics, inc. ® (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a virtual fireside chat at the 2022 bofa securities biotech smid cap conference, on thursday, december 8, 2022 at 9:10 a.m. et
FULC Ratings Summary
FULC Quant Ranking